Trial Profile
Evaluation of the efficacy of hysteroscopic photodynamic diagnosis using 5-aminolevulinic acid for diseases in the uterine cavity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Feb 2020
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Atypical endometrial hyperplasia; Endometrial cancer; Uterine diseases
- Focus Diagnostic use
- 10 Sep 2019 Status changed from active, no longer recruiting to completed.
- 09 Mar 2019 Status changed from recruiting to active, no longer recruiting.
- 09 Sep 2018 Status changed from not yet recruiting to recruiting.